immunotherapy companies
Companies whose enriched business profile is tagged “immunotherapy”, drawn from their SEC filings + website text. Sorted by market capitalization; every figure is delayed data from SEC EDGAR + Finnhub, shown with its as-of date.
- Regeneron Pharmaceuticals (REGN) Health Care — Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic areas. ask →
- CG ONCOLOGY INC (CGON) Health Care — An early-stage immuno-oncology company developing cretostimogene, a novel therapeutic candidate for high-risk and intermediate-risk non-muscle-invasive bladder cancer (NMIBC). ask →
- SELLAS LIFE SCIENCES GROUP INC (SLS) Health Care — SELLAS Life Sciences is a clinical-stage biotech developing targeted immunotherapies and small molecule inhibitors to treat a variety of hematologic and solid tumor cancers. ask →
- BICARA THERAPEUTICS INC (BCAX) Health Care — Bicara Therapeutics is developing a pipeline of bifunctional antibodies that precisely target and neutralize both EGFR and TGF-β pathways to improve treatment outcomes in solid tumors. ask →
- JANUX THERAPEUTICS INC (JANX) Health Care — Janux Therapeutics is a clinical-stage biotech developing next-generation, tumor-activated bispecific immunotherapies to improve the safety and efficacy of cancer and autoimmune treatments. ask →
- REPLIMUNE GROUP INC (REPL) Health Care — Replimune is developing engineered oncolytic viruses that directly kill tumors while triggering systemic anti-tumor immunity, with its lead candidate RP1 in combination therapy for melanoma patients who have failed checkpoint inhibitors. ask →
- ARTIVA BIOTHERAPEUTICS INC (ARTV) Health Care — Artiva Biotherapeutics develops allogeneic natural killer cell immunotherapies for cancer, with its lead candidate AlloNK advancing through clinical trials. ask →
- SAB BIOTHERAPEUTICS INC (SABS) Health Care — SAB Biotherapeutics produces fully human polyclonal antibodies via engineered cattle to treat autoimmune diseases, with SAB-142 in Phase 2b trials for type 1 diabetes. ask →
- TRISALUS LF SC CM A (TLSI) Health Care — TriSalus is a medical technology company integrating proprietary pressure-enabled drug delivery devices with immunotherapeutics to improve outcomes for patients with liver and pancreatic cancer. ask →
- ACUMEN PHARMACEUTICALS INC (ABOS) Health Care — Clinical-stage biotech developing sabirnetug, a monoclonal antibody that targets amyloid-beta oligomers to modify disease progression in Alzheimer's patients, with Phase 2 results expected in late 2026. ask →
- Cue Biopharma, Inc. (CUE) Health Care — Cue Biopharma engineers injectable biologics that selectively modulate disease-specific T cells to restore immune tolerance in autoimmune diseases and activate anti-tumor immunity in cancer. ask →
- CONTEXT THERAPEUTICS INC (CNTX) Health Care — Clinical-stage biopharmaceutical company developing T-cell engaging bispecific antibodies to treat solid tumors by redirecting immune cells against cancer cells. ask →
Not quite it? Describe exactly what you want →
Frequently asked
What are the largest immunotherapy companies?
By market capitalization, the largest immunotherapy companies in the catalog include Regeneron Pharmaceuticals (REGN), CG ONCOLOGY INC (CGON), SELLAS LIFE SCIENCES GROUP INC (SLS), BICARA THERAPEUTICS INC (BCAX), JANUX THERAPEUTICS INC (JANX).
How many immunotherapy companies does stocks-llm track?
stocks-llm currently lists 12 immunotherapy companies (as of 2026-07-22), each with dated fundamentals from SEC EDGAR and Finnhub. Informational only — not financial advice.
Data: SEC EDGAR (filings) + Finnhub (fundamentals, delayed daily-close). Figures shown with their as-of date.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.